14-Oct-2026 - Fintel JP Morgan Downgrades Leidos Holdings to Neutral from Overweight Fintel reports that on October 8, 2026, JP Morgan downgraded their outlook for Leidos Holdings (BIT:1LDOS) from Overweight to Neutral. Prior to this rating action, JP Morgan maintained an Overweight ...
13-Oct-2026 - Yahoo Finance Leidos Wins $317.9 Million US Defense Health Agency Contract Leidos Holdings (LDOS) won a $317.9 million contract from the US Defense Health Agency to offer system reintegration, software licensing, and hosting services for the electronic h ...
8-Oct-2026 - Fintel JP Morgan downgrades Leidos Holdings to neutral from overweight Fintel reports that on October 8, 2026, JP Morgan downgraded their outlook for Leidos Holdings (BMV:LDOS) from Overweight to Neutral. This rating action follows a prior action on July 13, 2026, when ...
7-Oct-2026 - Yahoo Finance JPMorgan Downgrades Leidos to Neutral From Overweight, Price Target is $142 Leidos (LDOS) has an average rating of overweight and mean price target of $152.07, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major ...
14-Oct-2026 - Fintel JP Morgan Downgrades Leidos Holdings to Neutral from Overweight Fintel reports that on October 8, 2026, JP Morgan downgraded their outlook for Leidos Holdings (BIT:1LDOS) from Overweight to Neutral. Prior to this rating action, JP Morgan maintained an Overweight ...
13-Oct-2026 - Yahoo Finance Leidos Wins $317.9 Million US Defense Health Agency Contract Leidos Holdings (LDOS) won a $317.9 million contract from the US Defense Health Agency to offer system reintegration, software licensing, and hosting services for the electronic h ...
8-Oct-2026 - Fintel JP Morgan downgrades Leidos Holdings to neutral from overweight Fintel reports that on October 8, 2026, JP Morgan downgraded their outlook for Leidos Holdings (BMV:LDOS) from Overweight to Neutral. This rating action follows a prior action on July 13, 2026, when ...
7-Oct-2026 - Yahoo Finance JPMorgan Downgrades Leidos to Neutral From Overweight, Price Target is $142 Leidos (LDOS) has an average rating of overweight and mean price target of $152.07, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major ...
